The purpose and effect of the proposed rule is to include K-2 as a drug tested for on Form DC6-2066, Reasonable Suspicion Testing Tracking.
RULE NO.:RULE TITLE:
33-602.2035Inmate Substance Abuse Testing
PURPOSE AND EFFECT: The purpose and effect of the proposed rule is to include K-2 as a drug tested for on Form DC6-2066, Reasonable Suspicion Testing Tracking.
SUMMARY: To include K-2 as a drug tested for on Form DC6-2006.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:
The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.
The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: upon review of the proposed changes to these rules and incorporated forms, the department has determined that the amendments will not exceed any one of the economic analysis criteria in a SERC as set forth in Section 120.541(2)(a), F.S.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
RULEMAKING AUTHORITY: 944.09, 944.473 FS.
LAW IMPLEMENTED: 944.09, 944.472, 944.473 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: LaDawna Fleckenstein, 501 South Calhoun Street, Tallahassee, Florida 32399-2500
THE FULL TEXT OF THE PROPOSED RULE IS:
33-602.2035 Inmate Substance Abuse Testing.
The Office of Institutions shall be responsible for the development and implementation of the department’s substance abuse testing program.
(1) through (2) No change.
(3) Procedures.
(a) through (e) No change.
(f) Other on-site testing device procedures.
1. No change.
2. All correctional facilities shall maintain a record of all reasonable suspicion substance abuse tests conducted. This record shall be maintained by the correctional officer chief or designee. Form DC6-2066, Reasonable Suspicion Testing Tracking, shall be utilized for this purpose. Form DC6-2066 is hereby incorporated by reference. Copies of the form are available from the Forms Control Administrator, 501 S. Calhoun Street, Tallahassee, Florida 32399-2500, http://www.flrules.org/Gateway/reference.asp?No=Ref-02089. The effective date of the form is ____ 2-13.
(g) No change.
Rulemaking Authority 944.09, 944.473 FS. Law Implemented 944.09, 944.472, 944.473 FS. History–New 2-8-00, Amended 2-5-01, Formerly 33-602.2045, Amended 7-2-02, 2-19-07, 7-29-08, 8-26-09, 2-10-10, 11-28-10, 1-11-12, Formerly 33-108.101, Amended 2-17-13,_________.
NAME OF PERSON ORIGINATING PROPOSED RULE: James Upchurch, Assistant Secretary of Institutions
NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Michael D. Crews, Secretary
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: February 10, 2014
DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: January 29, 2014
Document Information
- Comments Open:
- 2/13/2014
- Summary:
- To include K-2 as a drug tested for on Form DC6-2006.
- Purpose:
- The purpose and effect of the proposed rule is to include K-2 as a drug tested for on Form DC6-2066, Reasonable Suspicion Testing Tracking.
- Rulemaking Authority:
- 944.09, 944.473 FS
- Law:
- 944.09, 944.472, 944.473 FS
- Contact:
- LaDawna Fleckenstein, 501 South Calhoun Street, Tallahassee, Florida 32399-2500.
- Related Rules: (1)
- 33-602.2035. Inmate Substance Abuse Testing